Concepedia

Esther C.Y. Lee

EC

Statistics

Publications

6

Citations

144

H-Index

6

Active since

2011

Affiliations

Pfizer (United States)(Current)

Esther C.Y. Lee is an author at Pfizer (United States) specializing in pharmacology, receptor pharmacology, and drug discovery.

Publications per year

2011–2018

6

Publications

6

The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitus

Angel Guzmán-Pérez, Jeffrey A. Pfefferkorn, Esther C.Y. Lee et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 40 citations · Full text

, , +12

Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example

Markus Boehm, David Hepworth, Paula M. Loria et al. · ACS Medicinal Chemistry Letters · 2013 · 28 citations · Full text

, , +17

A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicity

Kevin J. Filipski, Jianwei Bian, David C. Ebner et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 26 citations · Full text

, , +16

Optimization of Metabolic and Renal Clearance in a Series of Indole Acid Direct Activators of 5′-Adenosine Monophosphate-Activated Protein Kinase (AMPK)

David J. Edmonds, Daniel W. Kung, Amit S. Kalgutkar et al. · Journal of Medicinal Chemistry · 2018 · 19 citations · Full text

, , +17

Identification of a novel conformationally constrained glucagon receptor antagonist

Esther C.Y. Lee, Meihua Tu, Benjamin D. Stevens et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 17 citations

, , +12

1–5 of 6